Naoya Uchida Selected Research

p 230 (p230)

6/2009	Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector.
7/2003	Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoya Uchida Research Topics

Disease

20	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 01/2017
4	Thalassemia 01/2022 - 11/2019
3	Leukemia 01/2021 - 06/2009
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2019 - 11/2019
2	Anemia 11/2017 - 05/2010
2	Infections 02/2014 - 09/2013
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Chronic Pain 11/2021
1	Diabetes Insipidus 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	primary familial and congenital Polycythemia 01/2021
1	Inflammation (Inflammations) 06/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2019
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 11/2017
1	Hemorrhage 11/2017
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 11/2017
1	Tinnitus 01/2016
1	Headache (Headaches) 01/2016
1	Cyanosis 01/2016
1	Altitude Sickness (Mountain Sickness) 01/2016
1	Malignant Fibrous Histiocytoma 04/2013
1	Exanthema (Rash) 07/2011
1	Sideroblastic Anemia 05/2010
1	Iron Overload 05/2010
1	Sickle Cell Trait 01/2010
1	Hemolysis 01/2009
1	Splenomegaly 11/2006
1	Thrombocytosis (Thrombocythemia) 07/2003
1	Leukocytosis (Pleocytosis) 07/2003

Drug/Important Bio-Agent (IBA)

12	GlobinsIBA 01/2022 - 01/2017
6	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2010
4	plerixafor FDA Link 01/2022 - 07/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2014
4	Fetal Hemoglobin (Hemoglobin F)IBA 12/2020 - 01/2016
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017 - 01/2010
2	Erythropoietin FDA Link 01/2021 - 04/2013
2	Immunologic Factors (Immunomodulators)IBA 02/2014 - 09/2013
2	p 230 (p230)IBA 06/2009 - 07/2003
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	AnticoagulantsIBA 01/2022
1	Citric Acid (Citrate)FDA LinkGeneric 01/2022
1	SolutionsIBA 01/2022
1	Alemtuzumab (Campath)FDA Link 01/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2021
1	CRISPR-Associated Protein 9IBA 06/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Arginine Vasopressin (Argipressin)IBA 01/2021
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	CytokinesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 06/2020
1	Busulfan (Busulfex)FDA Link 12/2019
1	Interleukin Receptor Common gamma SubunitIBA 12/2019
1	Sirolimus (Rapamycin)FDA Link 12/2019
1	CRISPR-Cas Systems Guide RNAIBA 11/2019
1	RibonucleoproteinsIBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2019
1	Vasopressins (Vasopressin)IBA 11/2017
1	Cyclophilin AIBA 09/2013
1	Leucine (L-Leucine)FDA Link 04/2013
1	AgglutininsIBA 07/2011
1	Heme (Haem)IBA 05/2010
1	Aconitate Hydratase (Aconitase)IBA 05/2010
1	IronIBA 05/2010
1	Iron Regulatory Protein 1IBA 05/2010
1	GlutaredoxinsIBA 05/2010
1	ElementsIBA 05/2010
1	fms-Like Tyrosine Kinase 3IBA 06/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2009
1	BilirubinIBA 01/2009
1	Imatinib Mesylate (Gleevec)FDA Link 11/2006

Therapy/Procedure

2	Blood Component Removal (Apheresis) 01/2022 - 11/2021
2	Therapeutics 01/2022 - 01/2021
1	Hematopoietic Stem Cell Transplantation 12/2019
1	Homologous Transplantation 12/2019
1	Transplantation 11/2019
1	Drug Therapy (Chemotherapy) 11/2017